Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice

Biochemical and Biophysical Research Communications

Volumn 340, Issue 4, 2006, Pages 1078-1084

  Tous, Mònica ^a   Ferré, Natàlia ^a   Rull, Anna ^a   Marsillach, Judit ^a   Coll, Blai ^a   Alonso Villaverde, Carlos ^a   Camps, Jordi ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Apo E deficient mice; Arteriosclerosis; Dietary cholesterol; Inflammation; Monocyte chemoattractant protein 1; PPARs; Steatohepatitis

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIOSCLEROSIS; ARTERY WALL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; DIET; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; INFLAMMATION; LIVER; MIGRATION INHIBITION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 30544434288     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.109     Document Type: Article

References (40)

1. G.M. Pendino, A. Mariano, P. Surace, C.A. Caserta, M.T. Fiorillo, A. Amante, S. Bruno, C. Mangano, I. Polito, F. Amato, R. Cotichini, T. Stroffolini, and A. Mele Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town Hepatology 41 2005 1151 1159
2. I. Friis-Liby, F. Aldenborg, P. Jerlstad, K. Rundstrom, and E. Bjornsson High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease Scand. J. Gastroenterol. 39 2004 864 869
3. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
4. A.E. Reid Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
5. H. Volzke, D.M. Robinson, V. Kleine, R. Deutscher, W. Hoffmann, J. Ludemann, U. Schminke, C. Kessler, and U. John Hepatic steatosis is associated with an increased risk of carotid atherosclerosis World J. Gastroenterol. 11 2005 1848 1853
6. A. Brea, D. Mosquera, E. Martin, A. Arizti, J.L. Cordero, and E. Ros Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study Arterioscler. Thromb. Vasc. Biol. 25 2005 1045 1050
7. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
8. F. Liao, A. Andalibi, J.H Qiao, H. Allayee, A.M. Fogelman, and A.J Lusis Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice J. Clin. Invest. 94 1994 877 884
9. M. Tous, N. Ferre, J. Camps, F. Riu, and J. Joven Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis Mol. Cell. Biochem. 268 2005 53 58
10. E.T. Yeh, H.V. Anderson, V. Pasceri, and J.T. Willerson C-reactive protein: linking inflammation to cardiovascular complications Circulation 104 2001 974 975
11. M. Klouche, S. Gottschling, V. Gerl, W. Hell, M. Husmann, B. Dorweiler, M. Messner, and S. Bhakdi Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages Arterioscler. Thromb. Vasc. Biol. 18 1998 1376 1385
12. Y. Seino, U. Ikeda, M. Takahashi, Y. Hojo, M. Irokawa, T. Kasahara, and K. Shimada Expression of monocyte chemoattractant protein-1 in vascular tissue Cytokine 7 1995 575 579
13. C. Alonso-Villaverde, B. Coll, S. Parra, M. Montero, N. Calvo, M. Tous, J. Joven, and L. Masana Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele Circulation 110 2004 2204 2209
14. F. Marra, R. DeFranco, C. Grappone, S. Milani, S. Pastacaldi, M. Pinzani, R.G. Romanelli, G. Laffi, and P. Gentillini Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration Am. J. Pathol. 152 1998 423 430
15. J. Marsillach, N. Bertran, J. Camps, N. Ferre, F. Riu, M. Tous, B. Coll, C. Alonso-Villaverde, and J. Joven The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease Clin. Biochem. 38 2005 1138 1140
16. R. Yu, J.S. Park, T. Kawada, and B.S. Kwon Alteration of a macrophages inflammatory protein-related protein-2 (MRP-2) response by high fat and cholesterol diet in mice Life. Sci. 70 2002 2535 2545
17. Y.L. Chen, Y.J. Chang, and M.J. Jiang Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits Atherosclerosis 143 1999 115 123
18. X. Yu, S. Dluz, D.T. Graves, L. Zhang, H.N. Antoniades, W. Hollander, S. Prusty, A.J. Valente, C.J. Schwartz, and G.E. Sonenshein Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates Proc. Natl. Acad. Sci. USA 89 1992 6953 6957
19. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
20. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
21. N. Marx, U. Schonbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ. Res. 83 1998 1097 1103
22. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
23. E. Fleck, W.A. Hsueh, and R.E. Law Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes Eur. J. Pharmacol. 401 2000 259 270
24. J.C. Escola-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordonez-Llanos, F. Gonzalez-Sastre, and F. Blanco-Vaca Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia J. Lipid Res. 41 2000 1328 1338
25. E. Vilella, J. Joven, M. Fernandez, S. Vilaro, J.D. Brunzell, T. Olivecrona, and G. Bengtsson-Olivecrona Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins J. Lipid Res. 34 1993 1555 1564
26. S.H. Zhang, R.L. Reddick, J.A. Piedrahita, and N. Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 1992 468 471
27. B. Paigen, A. Morrow, P.A. Holmes, D. Mitchell, and R.A. Williams Quantitative assessment of atherosclerotic lesions in mice Atherosclerosis 68 1987 231 240
28. K.F. Kusano, K. Nakamura, H. Kusano, N. Nishii, K. Banba, T. Ikeda, K. Hashimoto, M. Yamamoto, H. Fujio, A. Miura, K. Ohta, H. Morita, H. Saito, T. Emori, Y. Nakamura, I. Kusano, and T. Ohe Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis Circ. J. 68 2004 671 676
29. E. Lutgens, B. Faber, K. Schapira, C.T. Evelo, R. van Haaften, S. Heeneman, K.B. Cleutjens, A.P. Bijnens, L. Beckers, J.G. Porter, C.R. Mackay, P. Rennert, V. Bailly, M. Jarpe, B. Dolinski, V. Koteliansky, T. de Fougerolles, and M.J. Daemen Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody Circulation 111 2005 3443 3452
30. W. Ni, S. Kitamoto, M. Ishibashi, M. Usui, S. Inoue, K. Hiasa, Q. Zhao, K. Nishida, A. Takeshita, and K. Egashira Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice Arterioscler. Thromb. Vasc. Biol. 24 2004 534 539
31. M. Namiki, S. Kawashima, T. Yamashita, M. Ozaki, T. Hirase, T. Ishida, N. Inoue, K. Hirata, A. Matsukawa, R. Morishita, Y. Kaneda, and M. Yokoyama Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 22 2002 115 120
32. S. Inoue, K. Egashira, W. Ni, S. Kitamoto, M. Usui, K. Otani, M. Ishibashi, K. Hiasa, K. Nishida, and A. Takeshita Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice Circulation 106 2002 2700 2706
33. W. Li, T. Asagami, H. Matsushita, K.H. Lee, and P.S. Tsao Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice J. Pharmacol. Exp. Ther. 313 2005 557 562
34. G.G. Schwartz, and A.G. Olsson The case for intensive statin therapy after acute coronary syndromes Am. J. Cardiol. 96 2005 45 53
35. C.H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W.A. Boisvert, R.M. Evans, and L.K. Curtiss Transcriptional repression of atherogenic inflammation: modulation by PPARdelta Science 302 2003 453 457
36. T.L. Graham, C. Mookherjee, K.E. Suckling, C.N. Palmer, and L. Patel The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice Atherosclerosis 181 2005 29 37
37. J.P. van Wijk, E.J. de Koning, M.C. Cabezas, J. op't Roodt, J. Joven, T.J. Rabelink, and A.I. Hoepelman Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial Ann. Intern. Med. 143 2005 337 346
38. T. Tanaka, Y. Fukunaga, H. Itoh, K. Doi, J. Yamashita, T.H. Chun, M. Inoue, K. Masatsugu, T. Saito, N. Sawada, S. Sakaguchi, H. Arai, and K. Nakao Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration Eur. J. Pharmacol. 508 2005 255 265
39. D.M. Tham, B. Martin-McNulty, Y.X. Wang, D.W. Wilson, R. Vergona, M.E. Sullivan, W. Dole, and J.C. Rutledge Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs Physiol. Genomics 11 2002 21 30
40. J. Plutzky The vascular biology of atherosclerosis Am. J. Med. 115 2003 55 61